Cargando…

APOE as potential biomarkers of moyamoya disease

OBJECTIVE: The mechanisms underpinning Moyamoya disease (MMD) remain unclear, and effective biomarkers remain unknown. The purpose of this study was to identify novel serum biomarkers of MMD. METHODS: Serum samples were collected from 23 patients with MMD and 30 healthy controls (HCs). Serum protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Haibin, Xu, Jiang, Sun, Jiarong, Duan, Jian, Xiao, Jinlin, Ren, Quan, Zhou, Pengfei, Yan, Jian, Li, Youping, Xiong, Xiaoxing, Zeng, Erming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203507/ https://www.ncbi.nlm.nih.gov/pubmed/37228412 http://dx.doi.org/10.3389/fneur.2023.1156894

Ejemplares similares

The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

Non-invasive Urinary Biomarkers in Moyamoya Disease
por: Sesen, Julie, et al.
Publicado: (2021)

MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease
por: Lu, Junlin, et al.
Publicado: (2021)

Moyamoya: An Update and Review
por: Berry, James A, et al.
Publicado: (2020)

Editorial: Moyamoya disease
por: Gu, Yuxiang
Publicado: (2022)

Potential predictors for progression of moyamoya disease: A systematic review and meta-analysis
por: Cao, Jun, et al.
Publicado: (2023)

TGFβ1 as a Predictive Biomarker for Collateral Formation Within Ischemic Moyamoya Disease
por: Chen, Yuanbing, et al.
Publicado: (2022)

Epidemiology of Moyamoya Angiopathy in Eastern India
por: Das, Shambaditya, et al.
Publicado: (2022)

Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study
por: Wang, Yixuan, et al.
Publicado: (2022)

Burden of dilated perivascular spaces in patients with moyamoya disease and moyamoya syndrome is related to middle cerebral artery stenosis
por: Han, Guangsong, et al.
Publicado: (2023)

Recognition of the Effect of Indirect Revascularization for Moyamoya Disease: The Balance Between the Stage Progression and Neoangiogenesis
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

Moyamoya Disease: A Review of Current Literature
por: Gupta, Apurv, et al.
Publicado: (2020)

Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
por: Fox, Brandon M., et al.
Publicado: (2021)

Western Moyamoya Phenotype: A Scoping Review
por: Miller, Raphael, et al.
Publicado: (2021)

Surgical Management of Failed Revascularization in Moyamoya Vasculopathy
por: Lucia, Kristin, et al.
Publicado: (2021)

Application of DTI and fMRI in moyamoya disease
por: Hao, Xiaokuan, et al.
Publicado: (2022)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
por: Zhang, Xin, et al.
Publicado: (2022)

Angiographic Outcomes of Direct and Combined Bypass Surgery in Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis
por: Liu, Tingting, et al.
Publicado: (2023)

A Patient With Multiple Sclerosis and Coexisting Moyamoya Disease: Why and How
por: Si, Xiaoli, et al.
Publicado: (2020)

Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
por: Camacho, Jessica, et al.
Publicado: (2019)

Characterization of Inpatient Moyamoya in the United States: 1988–2004
por: Lee, Darrin J., et al.
Publicado: (2011)

Moyamoya Disease in a Six Month Caucasian Female
por: Moore, Faith D, et al.
Publicado: (2020)

Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease
por: Santoro, Jonathan D., et al.
Publicado: (2021)

Corrigendum: Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
por: Fox, Brandon M., et al.
Publicado: (2021)

Editorial: Moyamoya disease – natural history and therapeutic challenges
por: Svedung Wettervik, Teodor, et al.
Publicado: (2023)

Indirect Bypass With Pericranial Transposition for Moyamoya Syndrome in an Infant
por: Ajala, Rodiyah T, et al.
Publicado: (2023)

The relationship between hemoglobin and triglycerides in moyamoya disease: A cross-sectional study
por: Su, Yu, et al.
Publicado: (2022)

Hyperhomocysteinemia Is a Predictor for Poor Postoperative Angiogenesis in Adult Patients With Moyamoya Disease
por: He, Qiheng, et al.
Publicado: (2022)

Extracranial and Intracranial Vasculopathy With “Moyamoya Phenomenon” in Association With Alagille Syndrome
por: Delaney, Siobhan, et al.
Publicado: (2019)

Clinical and Radiological Outcomes After Revascularization of Hemorrhagic Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2020)

Moyamoya Disease in a Young Female With Neurofibromatosis Type 1
por: Mehkri, Yusuf, et al.
Publicado: (2021)

Parent artery occlusion for ruptured aneurysms in moyamoya vessels or on collaterals
por: Zhou, Zibo, et al.
Publicado: (2023)

Clinical value of the systemic immune-inflammation index in moyamoya disease
por: Liu, Erheng, et al.
Publicado: (2023)

Multimodal evaluation of the bloodstream alteration before and after combined revascularization for Moyamoya disease
por: Cao, Lei, et al.
Publicado: (2023)

Postoperative cerebral infarction after revascularization in patients with moyamoya disease: Incidence and risk factors
por: Wang, Jiaxiong, et al.
Publicado: (2022)

Application of intraoperative infrared thermography in bypass surgery for adult moyamoya syndrome: A preliminary study
por: Lin, Jinghui, et al.
Publicado: (2023)

Cerebral Hemodynamic Changes After Revascularization in Patients With Hemorrhagic Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2020)

Moyamoya Disease in a 13-Month-Old Middle Eastern Boy
por: M. Ali, Nashwa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b2n82rm8s508gugipo7pljogo2